Clinical and morphological characterization for detection of hypermutation in colorectal cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e15647
Abstract: e15647Background: Hypermutation, which is a molecular subtype with high tumor mutation burden (TMB), has been recognized as a biomarker of anti-PD-1 therapy in many cancers. Hypermutation can be de... read more here.
Keywords: detection hypermutation; clinical morphological; characterization detection; hypermutation ... See more keywords